Position in GH
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$248,899
New position
Shares Held
1,659
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#429
of 593 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $21,207,266 across 19 Diagnostics & Research names. GH ranks #18 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
11,918 | $5,975,208 | |
| 2 | DHR |
Danaher Corp /De/
|
15,391 | $2,931,677 | |
| 3 | LH |
Labcorp Holdings Inc.
|
7,651 | $2,142,280 | |
| 4 | A |
Agilent Technologies, Inc.
|
9,423 | $1,251,657 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2,125 | $1,118,685 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
5,581 | $1,078,360 | |
| 7 | ILMN |
Illumina, Inc.
|
5,103 | $897,260 | |
| 8 | NEO |
Neogenomics Inc
|
60,940 | $889,114 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $248,899 | 1,659 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||